Greenleaf Trust decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 30.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 64,701 shares of the company’s stock after selling 28,666 shares during the period. Greenleaf […]